Because the effect of full-length AML1-ETO on apoptosis does not favor leukemogenesis, we proposed that mutation of caspase-3-targeted sites that would result in the abrogation of apoptosis-enhancing effect might exist in t(8;21)-positive AML patients. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.